Bordetella holmesii bacteremia in sickle cell disease

Pediatric Blood and Cancer

Volumn 51, Issue 6, 2008, Pages 814-816

  McCavit, Timothy L ^a,b,c   Grube, Steve ^a,b   Revell, Paula ^b   Quinn, Charles T ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b CHILDREN S MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Asplenia; Bacteremia; Bordetella holmesii; Sickle cell disease

Indexed keywords

CEFIXIME; CEFTRIAXONE; CLINDAMYCIN; LEVOFLOXACIN;

ADOLESCENT; ANKLE SPRAIN; ANTIBIOTIC THERAPY; ARTICLE; BACKACHE; BACTEREMIA; BACTERIAL GROWTH; BACTERIUM CULTURE; BLOOD CULTURE; BORDETELLA; BORDETELLA HOLMESII; CASE REPORT; CELLULITIS; CHILL; CLINICAL FEATURE; COUGHING; DISEASE COURSE; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA;

ADOLESCENT; ANEMIA, SICKLE CELL; BACTEREMIA; BORDETELLA; BORDETELLA INFECTIONS; CELLS, CULTURED; CHILD; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 56849128508     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.21712     Document Type: Article

References (11)

1. Halasa NB, Shankar SM, Talbot TR, et al. Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine. Clin Infect Dis 2007;44:1428-1433.
2. Gaston MH, Verter JI, Woods G, et al. Prophylaxis with oral penecillin in children with sickle cell anemia. N Engl J Med 1986;314:1593-1599.
3. Ammann AJ, Addiego J, Wara DW, et al. Polyvalent pneumococcal polysaccharide immunization of patients with sickle cell anemia and patients with splenectomy. N Engl J Med 1977;297:897-900.
4. Weyant RS, Hollis DG, Weaver RE, et al. Bordetella holmesii sp. nov., a New Gram-Negative Species Associated with Septicemia. J Clin Microbiol 1995;33:1-7.
5. Shepard CW, Daneshvar MI, Kaiser RM, et al. Bordetella holmesii bacteremia: A newly recognized clinical entity among asplenic patients. Clin Infect Dis 2004;38:799-804.
6. Tang YW, Hopkins MK, Kolbert CP, et al. Bordetella holmesii-like organism associated with septicemia, endocarditis, and respiratory failure. Clin Infect Dis 1998;26:389-392.
7. Njamkepo E, Delisle F, Hagege I, et al. Bordetella holmesii isolated from a patient with sickle cell anemia: Analysis and comparison with other Bordetella holmesii isolates. Clin Microbiol Infect 2000;3:131-136.
8. Russell FM, Davis JM, Whipp MJ, et al. Severe Bordetella holmesii infection in a previously healthy adolescent confirmed by gene sequence analysis. Clin Infect Dis 2001;33:129-130.
9. Dorbecker C, Licht C, Korber F, et al. Community-acquired pneumonia due to Bordetella holmesii in a patient with frequently relapsing nephrotic syndrome. J Infect 2007;54:e203-e205.
10. Norris CFS-WK, McGowan KL. Positive blood cultures in sickle cell disease: Time to positivity and clinical outcome. J Pediatr Hematol/Oncol 2003;25:390-395.
11. Hardy DJ, Hulbert BB, Migneault PC. Time to detection of positive BacT/alert blood cultures and lack of need for routine subculture of 5- to 7-day negative cultures. J Clin Microbiol 1992;30:2743-2745.